Skip to main content
Log in

An alpha2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Nocturnal plasma melatonin concentration was significantly increased in ten normal volunteers following the administration of an alpha2 adrenoceptor antagonist, Org 3770 (30 mg). This result supports the existence of an alpha2 adrenergic influence on melatonin secretion in man and provides a possible clinical neuroendocrine marker of the action of an alpha2 antagonist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arendt J, Boikowski C, Franey C, Wright J, Marks V (1985) Immunoassay of 6-hydroxymelatonin sulphate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 60:1166–1173

    Google Scholar 

  • Checkley SA, Thompson C, Burton S, Franey, C, Arendt J (1985) Clinical studies of the effect of (+) and (-)-oxaprotiline upon noradrenaline uptake. Psychopharmacology 87:116–118

    Google Scholar 

  • Checkley SA, Winton F, Corn T, Franey C, Arendt J (1987) Effects of a phosphodiestrase inhibitor (rolipram) on the urinary excretion of 6-sulphatoxy melatonin in man. J Br Assoc Psychopharmacol 1:1–3

    Google Scholar 

  • Cowen PJ, Fraser S, Sammons R, Green AR (1983) Atenolol reduces plasma melatonin concentration in man. Br J Clin Pharmacol 15:579–581

    Google Scholar 

  • Cowen PJ, Green AR, Grahame-Smith DE, Braddock LE (1985) Plasma melatonin during desmethylimiptamine treatment: evidence for changes in noradrenergic transmission. Br J Clin Pharmacol 19:799–805

    Google Scholar 

  • Craft CM, Morgan WW, Jones DJ, Reiter RJ (1985) Hampster and rat pineal gland beta adrenoceptor characterisation with iodopindolol and the effect of decreased catecholamine synthesis on the receptor. J Pineal Res 2:51–66

    Google Scholar 

  • Deguchi T (1973) Role of the beta adrenergic receptor in the elevation of adenosine cyclic 3′5′-monophosphate and induction of serotonin N-acetyltransferase in rat pineal glands. Mol Pharmacol 9:184–190

    Google Scholar 

  • Franey C, Aldous M, Burton S, Checkley SA, Arendt J (1986) Acute treatment with desipramine stimulates melatonin and 6-sulphatoxy melatonin production in man. Br J Clin Pharmacol 22:73–79

    Google Scholar 

  • Fraser S., Cowen P, Franklin M, Franey C, Arendt J (1983) Direct radioimmunoassay for melatonin in plasma. Clin Chem 29:396–397

    Google Scholar 

  • Grasby PM, Cowen PJ (1988) The effect of clonidine and bright light on plasma melatonin. Hum Psychopharmacol 3:43–46

    Google Scholar 

  • Ibuka N, Kawamura H (1975) Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesions. Brain Res 96:76–81

    Google Scholar 

  • Illnerova H, Vanecek J (1982) Two oscillator structure of the pace-maker controlling the circadian rhythm of N-acetyltransferase in the rat pineal gland. J Comp Physiol 145:539–548

    Google Scholar 

  • Klein DC, Moore RY (1979) Pineal N-acetyltransferase and hydroxyindole-O-methyltransferase control by the retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res 174:245–262

    Google Scholar 

  • Lewy AJ, Siever LJ, Uhde TW, Markey SP (1986) Clonidine reduces plasma melatonin levels. J Pharm Pharmacol 38:555–556

    Google Scholar 

  • Moore RY, Eichler VB (1972) Loss of circadian adrenal corticosterone rhythm following suprachiasmatic nucleus lesions in the rat. Brain Res 42:201–206

    Google Scholar 

  • Paanacker JE, Van Hal HJM (1987) Capillary gas chromatographic assay for the routine monitoring of the antidepressant mepirzepine in human plasma. J Chromatogr 417:203–207

    Google Scholar 

  • Palazidou E, Franey C, Arendt J, Stahl S, Checkley S (1988) Evidence for a functional role of alpha, adrenoceptors in the regulation of melatonin secretion in man. Psychoneuroendocrinology (in press)

  • Pelayo F, Dubocovich ML, Langer SR (1977) Regulation of noradrenaline release in the rat pineal through a negative feedback mechanism mediated by presynaptic alpha adrenoceptors. Eur J Pharmacol 45:317–318

    Google Scholar 

  • Pevet P (1983) The anatomy of the pineal gland. In: Relkin R (ed) The pineal gland Elsevier Biomedical, New York, pp 1–128

    Google Scholar 

  • Pinder R (1985) Alpha2 adrenoceptor antagonists antidepressants. Drugs of the Future 10:841–857

    Google Scholar 

  • Sugden D, Klein DC (1984) Rat pineal alpha-1 adrenoceptors: Identification and characterisation using [125I]iodo-2-[beta-(4-hydroxyphenyl)-ethylaminomethyl]tetralone. Endocrinology 114:435–440

    Google Scholar 

  • Wirz-Justice A (1987) Circadian rhythms in mammalian neurotransmitter receptors. Prog Neurobiol 29:219–259

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palazidou, E., Papadopoulos, A., Sitsen, A. et al. An alpha2 adrenoceptor antagonist, Org 3770, enhances nocturnal melatonin secretion in man. Psychopharmacology 97, 115–117 (1989). https://doi.org/10.1007/BF00443424

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00443424

Key words

Navigation